ENvue Medical, Inc. SEC filings FEED

ENvue Medical, Inc. has 551 filings in SEC EDGAR's recent list, going back to May 5, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (material agreement, new debt, bylaw or fiscal year change). The company's fiscal year ends on December 31.

ENvue Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, New debt, Bylaw or fiscal year change
Oct 14, 2026 Oct 8, 2026
EFFECT Filing Sep 3, 2026 —
8-K Current report
Bylaw or fiscal year change, Other events
Aug 31, 2026 Aug 28, 2026
10-Q Quarterly report Aug 17, 2026 Jun 30, 2026
NT 10-Q Filing Aug 14, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Aug 14, 2026 Aug 14, 2026
8-K Current report
Material agreement
Aug 12, 2026 Aug 12, 2026
S-3 Shelf registration Aug 10, 2026 —
DEF 14A Proxy statement Jul 24, 2026 Jul 24, 2026
PRE 14A Preliminary proxy statement Jul 14, 2026 Jul 14, 2026
8-K Current report
Officer or director change
Jul 14, 2026 Jul 14, 2026
8-K Current report
Listing notice
Jul 10, 2026 Jul 10, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 22, 2026 —
4 Insider transaction Jun 22, 2026 Jun 22, 2026
EFFECT Filing May 28, 2026 —
424B3 Prospectus May 28, 2026 —
CORRESP Letter to the SEC May 26, 2026 —
UPLOAD Letter from the SEC May 26, 2026 —
S-3 Shelf registration May 18, 2026 —
10-Q Quarterly report May 18, 2026 Mar 31, 2026
NT 10-Q Filing May 15, 2026 Mar 31, 2026
144 Notice of proposed sale May 13, 2026 —
4 Insider transaction Apr 17, 2026 Apr 15, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 17, 2026 —
10-K Annual report Apr 15, 2026 Dec 31, 2025
NT 10-K Filing Mar 31, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 6, 2026 —
3 Initial insider ownership Feb 26, 2026 Dec 18, 2025
3 Initial insider ownership Feb 11, 2026 Jan 14, 2026
4 Insider transaction Feb 11, 2026 Jan 14, 2026
SCHEDULE 13D Ownership over 5% (active) Feb 11, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 6, 2026 —
8-K Current report
Officer or director change
Feb 6, 2026 Feb 2, 2026
3/A Primary document Feb 5, 2026 Jan 30, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
3 Initial insider ownership Feb 4, 2026 Feb 2, 2026
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Jan 30, 2026 Jan 30, 2026
3 Initial insider ownership Jan 12, 2026 Feb 14, 2025
8-K Current report
Officer or director change
Dec 30, 2025 Dec 24, 2025
3 Initial insider ownership Dec 29, 2025 Dec 4, 2025
8-K Current report
Officer or director change
Dec 23, 2025 Dec 17, 2025
EFFECT Filing Dec 18, 2025 —
3 Initial insider ownership Dec 18, 2025 Dec 4, 2025
3 Initial insider ownership Dec 18, 2025 Dec 4, 2025
424B3 Prospectus Dec 18, 2025 —
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Dec 12, 2025 Dec 8, 2025
S-3/A Filing Dec 10, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 5, 2025 Dec 4, 2025
8-K Current report
Regulation FD disclosure
Nov 19, 2025 Nov 19, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
ARS Annual report to shareholders Nov 10, 2025 Dec 31, 2024
DEF 14A Proxy statement Nov 10, 2025 Nov 10, 2025
PRE 14A Preliminary proxy statement Oct 30, 2025 Oct 30, 2025
8-K Current report
Officer or director change
Oct 30, 2025 Oct 30, 2025
S-3/A Filing Oct 6, 2025 —
8-K Current report
Material agreement, Other events
Sep 17, 2025 Sep 16, 2025
424B5 Prospectus supplement Sep 17, 2025 —
S-3 Shelf registration Sep 15, 2025 —
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025
8-K Current report
Auditor change, Officer or director change
Aug 14, 2025 Aug 11, 2025
NT 10-Q Filing Aug 14, 2025 Jun 30, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Aug 8, 2025 Aug 8, 2025
8-K Current report
Officer or director change
Jul 30, 2025 Jul 24, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Jul 22, 2025 Jul 18, 2025
8-K Current report
Shareholder vote results
Jul 18, 2025 Jul 17, 2025
8-K Current report
Other events
Jul 11, 2025 Jul 11, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jul 9, 2025 Jul 8, 2025
DEFA14A Additional proxy material Jun 25, 2025 —
DEF 14A Proxy statement Jun 20, 2025 Jun 20, 2025
PRE 14A Preliminary proxy statement Jun 9, 2025 Jun 9, 2025
8-K Current report
Officer or director change, Other events
Jun 4, 2025 Jun 4, 2025
10-Q Quarterly report May 20, 2025 Mar 31, 2025
SCHEDULE 13G Ownership over 5% (passive) May 19, 2025 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
May 16, 2025 May 12, 2025
424B4 Prospectus May 16, 2025 —
NT 10-Q Filing May 15, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
EFFECT Filing May 14, 2025 —
CORRESP Letter to the SEC May 14, 2025 —
CORRESP Letter to the SEC May 14, 2025 —
S-1/A Amended registration statement May 14, 2025 —
S-1/A Amended registration statement May 12, 2025 —
S-1/A Amended registration statement Apr 29, 2025 —
S-1/A Amended registration statement Apr 22, 2025 —
8-K Current report
Material agreement, New debt, Other events
Apr 11, 2025 Apr 9, 2025
8-K Current report
Officer or director change
Apr 3, 2025 Apr 1, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Mar 14, 2025 Mar 14, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Mar 12, 2025 Mar 12, 2025
8-K Current report
Shareholder vote results
Feb 25, 2025 Feb 24, 2025
UPLOAD Letter from the SEC Feb 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
S-1 Registration statement Feb 14, 2025 —
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Feb 14, 2025 Feb 14, 2025
DEF 14A Proxy statement Jan 27, 2025 Jan 27, 2025
PRE 14A Preliminary proxy statement Jan 16, 2025 Jan 16, 2025
8-K Current report
Unregistered share sale
Jan 7, 2025 Jan 7, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 6, 2025 Jan 6, 2025
4 Insider transaction Jan 3, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
4 Insider transaction Jan 2, 2025 Dec 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Dec 20, 2024 Dec 19, 2024
8-K Current report
Regulation FD disclosure
Dec 19, 2024 Dec 19, 2024
8-K Current report
Other events
Dec 11, 2024 Dec 11, 2024
8-K Current report
Listing notice
Nov 22, 2024 Nov 19, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
ARS Annual report to shareholders Oct 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Oct 29, 2024 —
DEF 14A Proxy statement Oct 29, 2024 Oct 29, 2024
8-K Current report
Listing notice
Oct 11, 2024 Oct 8, 2024
8-K Current report Oct 7, 2024 Oct 2, 2024
8-K Current report
Officer or director change
Sep 25, 2024 Sep 20, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Regulation FD disclosure
May 16, 2024 May 16, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-K/A Amended annual report Apr 26, 2024 Dec 31, 2023
8-K Current report
Listing notice
Apr 15, 2024 Apr 10, 2024
10-K/A Amended annual report Apr 9, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Apr 9, 2024 Apr 9, 2024
10-K Annual report Apr 8, 2024 Dec 31, 2023
NT 10-K Filing Apr 1, 2024 Dec 31, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Mar 28, 2024 Mar 22, 2024
4 Insider transaction Feb 26, 2024 Jan 23, 2024
4 Insider transaction Feb 26, 2024 Jan 23, 2024
4 Insider transaction Feb 23, 2024 Jan 23, 2024
4 Insider transaction Feb 23, 2024 Jan 23, 2024
4 Insider transaction Feb 23, 2024 Jan 23, 2024
4 Insider transaction Feb 23, 2024 Jan 23, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
DEFA14A Additional proxy material Jan 17, 2024 —
8-K Current report
Other events
Jan 17, 2024 Jan 17, 2024
8-K Current report
Auditor change
Dec 11, 2023 Dec 6, 2023
4 Insider transaction Dec 6, 2023 Nov 15, 2023
4 Insider transaction Dec 6, 2023 Nov 15, 2023
4 Insider transaction Dec 4, 2023 Nov 15, 2023
4 Insider transaction Dec 4, 2023 Nov 15, 2023
4 Insider transaction Dec 4, 2023 Nov 15, 2023
4 Insider transaction Dec 4, 2023 Nov 15, 2023
4 Insider transaction Dec 4, 2023 Nov 15, 2023
4 Insider transaction Dec 4, 2023 Nov 15, 2023
4 Insider transaction Dec 4, 2023 Nov 15, 2023
8-K Current report
Officer or director change
Dec 4, 2023 Nov 29, 2023
DEFA14A Additional proxy material Nov 30, 2023 —
DEF 14A Proxy statement Nov 30, 2023 Nov 29, 2023
8-K Current report
Regulation FD disclosure
Nov 28, 2023 Nov 28, 2023
8-K Current report
Other events
Nov 21, 2023 Nov 20, 2023
8-K Current report
Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Regulation FD disclosure
Nov 7, 2023 Nov 7, 2023
8-K Current report
Regulation FD disclosure
Sep 27, 2023 Sep 27, 2023
EFFECT Filing Sep 21, 2023 —
424B3 Prospectus Sep 21, 2023 —
RW Filing Sep 21, 2023 —
CORRESP Letter to the SEC Sep 19, 2023 —
UPLOAD Letter from the SEC Sep 19, 2023 —
D Filing Sep 13, 2023 —
S-3 Shelf registration Sep 12, 2023 —
8-K Current report
Regulation FD disclosure
Sep 6, 2023 Sep 6, 2023
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 1, 2023 Aug 30, 2023
8-K Current report
Regulation FD disclosure
Aug 30, 2023 Aug 30, 2023
8-K Current report
Regulation FD disclosure
Aug 29, 2023 Aug 29, 2023
8-K Current report
Regulation FD disclosure
Aug 28, 2023 Aug 28, 2023
8-K Current report
Material agreement, Other events
Aug 23, 2023 Aug 22, 2023
EFFECT Filing Aug 11, 2023 —
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
CORRESP Letter to the SEC Aug 9, 2023 —
UPLOAD Letter from the SEC Aug 9, 2023 —
S-1/A Amended registration statement Aug 7, 2023 —
S-3 Shelf registration Aug 1, 2023 —
8-K Current report
Other events
Jul 20, 2023 Jul 19, 2023
S-1 Registration statement Jul 17, 2023 —
8-K Current report
Shareholder vote results
Jun 21, 2023 Jun 21, 2023
8-K Current report
Regulation FD disclosure
Jun 14, 2023 Jun 14, 2023
8-K Current report
Listing notice
May 25, 2023 May 23, 2023
DEFA14A Additional proxy material May 18, 2023 —
8-K Current report
Regulation FD disclosure
May 18, 2023 May 18, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 May 1, 2023
8-K Current report Apr 19, 2023 Apr 19, 2023
10-K Annual report Apr 17, 2023 Dec 31, 2022
NT 10-K Filing Mar 31, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Mar 28, 2023 Mar 28, 2023
8-K Current report
Regulation FD disclosure
Mar 21, 2023 Mar 21, 2023
8-K Current report
Regulation FD disclosure
Mar 14, 2023 Mar 14, 2023
8-K Current report
Other events
Mar 3, 2023 Feb 28, 2023
8-K Current report
Regulation FD disclosure
Feb 22, 2023 Feb 22, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Feb 8, 2023 Feb 8, 2023
8-K Current report
Regulation FD disclosure
Jan 18, 2023 Jan 18, 2023
4 Insider transaction Jan 5, 2023 Jan 5, 2023
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Dec 15, 2022 Dec 15, 2022
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 1, 2022 Nov 29, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
FEED (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tyler, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1326706
Former names
NanoVibronix, Inc. (until Dec 12, 2025); Nano Vibronix, Inc. (until Mar 25, 2014); Nano Vibronix Inc (until May 5, 2005)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.